Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Share with a colleague
Pharmaceutical Executive Europe  E-News
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecutive
 
Survey
What is the primary social media tool you use for drug development research?
LinkedIn 30%

Facebook

10%
Twitter 15%
Google+ 10%
Chat rooms 5%
Article comments 20%
Blogs 10%

Talk to us:
jupton@advanstar.com

Advertise with us:
Dtaylor-higgins@advanstar.com

6 August, 2013
Pharm Exec’s 2013 Emerging Pharma Leaders
Meet Pharm Exec’s 15 Emerging Pharma Leaders of 2013. These trendsetters represent the future of an industry that knows it must change. The question is how, and to what? ...Read more
GSK's China Crisis: One Company, One Defining Moment
With GlaxoSmithKline the chief target of the Chinese government’s assault on corruption in the medicines, those commanding heights around CSR don’t look so high right now ... Read more
Read the Latest Pharm Exec Global Digest: Compliance Special
In this month’s issue: Pharma and the UK Bribery Act: Two Years On; Transparency and Data Protection: A Delicate Balance; Compliance’s Place in the C-Suite; Five Compliance Questions to Ask Yourself; and much more ... Read more
The Curious Case of AstraZeneca vs. ACE
Insurance contracts are a language game that must be played very carefully, as AstraZeneca learned. Mike Kelly and Andrew Dupre report ... Read more
PharmExec Releases New eBook: The Best of the Successful Product Manager's Handbook Volume II
In the second volume of this four-volume set from the pages of Pharmaceutical Executive,
learn to think outside the box to meet both timeless and newly emerging obstacles to success ... Read more

Products/Services Profiles
Sciformix
SciVigilance – Pharmacovigilance in a box
Scivigilance provides the powerful combination of streamlined processes, domain expertise and robust technology that integrates disparate data and enables the seamless flow, collection processing and analysis of data.  Scivigilance delivers significant time and cost savings, efficiency and compliance gains, all while delivering the highest quality outcomes. Read More
Also in this issue
Dangerous Liaisons: Pharma and Terrorism
Social Media’s Not So Scary. But What About Social Business?
European Pharma in Race for Horizon 2020 Funds